Δημοσιεύτηκε στις 24 Σεπ 2014
Flemming
Cassee discusses the challenges of assessing the safety of
nanoparticles used in commercial products, and what’s needed to develop
better policies on the their impact on human health and the environment.
Cassee is an inhalation toxicologist at the National Institute
for Public Health and the Environment, the Netherlands, and is also
Editor-in-Chief of the journal Particle and Fibre Toxicology.
For more on Flemming Cassee visit Biome online here: http://www.biomedcentral.com/biome/fl...
Biome is BioMed Central's online magazine for research highlights, comment and community news across biology and medicine.
For more, go to http://www.biomedcentral.com/biome
Cassee discusses the challenges of assessing the safety of
nanoparticles used in commercial products, and what’s needed to develop
better policies on the their impact on human health and the environment.
Cassee is an inhalation toxicologist at the National Institute
for Public Health and the Environment, the Netherlands, and is also
Editor-in-Chief of the journal Particle and Fibre Toxicology.
For more on Flemming Cassee visit Biome online here: http://www.biomedcentral.com/biome/fl...
Biome is BioMed Central's online magazine for research highlights, comment and community news across biology and medicine.
For more, go to http://www.biomedcentral.com/biome
Κατηγορία
Άδεια
Τυπική άδεια YouTube
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου